2C-B: Difference between revisions
>MeyveliPasta m Grammatics |
>Unity Grammatics |
||
Line 165: | Line 165: | ||
===Cardiac risk=== | ===Cardiac risk=== | ||
Users experience hypertension, hyperthermia and tachycardia at higher doses.<ref>Papaseit, Esther et al. “Acute Pharmacological Effects of 2C-B in Humans: An Observational Study” Frontiers in pharmacology vol. 9 206. 13 Mar. 2018, doi:10.3389/fphar.2018.00206| https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859368/</ref> As such, those with pre-existing heart conditions should avoid using 2C-B, and users monitor their temperature and heart-rate and respond accordingly. Heavy physical exertion while on 2C-B is discouraged. | Users have reported experience hypertension, hyperthermia and tachycardia at higher doses.<ref>Papaseit, Esther et al. “Acute Pharmacological Effects of 2C-B in Humans: An Observational Study” Frontiers in pharmacology vol. 9 206. 13 Mar. 2018, doi:10.3389/fphar.2018.00206| https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859368/</ref> As such, those with pre-existing heart conditions should avoid using 2C-B, and users monitor their temperature and heart-rate and respond accordingly. Heavy physical exertion while on 2C-B is discouraged. | ||
===Lethal dosage=== | ===Lethal dosage=== |